Improved criteria for clinical, laboratory, molecular and pathologic (2018 CLMP) diagnosis and staging of prefibrotic JAK2, CALR and MPL mutated myeloproliferative neoplasms
The broad spectrum of JAK2 V617F mutated trilinear myeloproliferative neoplasms (MPN) include

